Alan Lotvin - Apr 1, 2022 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP&President-PharmacyServices
Signature
/s/ Alan M. Lotvin
Stock symbol
CVS
Transactions as of
Apr 1, 2022
Transactions value $
$4,026,718
Form type
4
Date filed
4/5/2022, 07:28 PM
Previous filing
Feb 23, 2022
Next filing
Jul 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock Tax liability -$3.85M -38.1K -25.88% $101.09 109K Apr 1, 2022 Direct F1
holding CVS Common Stock 492 Apr 1, 2022 By Children's Trusts
holding CVS Stock Unit 30K Apr 1, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVS Stock Option Award $7.88M +78K $101.09 78K Apr 1, 2022 Common Stock 78K $101.09 Direct F2
holding CVS Phantom Stock Credits 554 Apr 1, 2022 Common Stock 554 $1.00 Direct F3, F4
holding CVS Stock Option 27.4K Apr 1, 2022 Common Stock 27.4K $104.82 Direct F5
holding CVS Stock Option 32.9K Apr 1, 2022 Common Stock 32.9K $78.05 Direct F6
holding CVS Stock Option 22.5K Apr 1, 2022 Common Stock 22.5K $62.21 Direct F7
holding CVS Stock Option 70.7K Apr 1, 2022 Common Stock 70.7K $54.19 Direct F8
holding CVS Stock Option 141K Apr 1, 2022 Common Stock 141K $58.34 Direct F9, F10
holding CVS Stock Option 121K Apr 1, 2022 Common Stock 121K $74.30 Direct F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Surrender of shares in payment of taxes due upon the vesting and settlement of PSUs on April 1, 2022.
F2 Option becomes exercisable in four equal installments, commencing 4/1/2023.
F3 Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F4 Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F5 Option became exercisable in four equal annual installments, commencing 4/1/2017.
F6 Option became exercisable in four equal annual installments, commencing 4/3/2018.
F7 Option became exercisable in four equal annual installments, commencing 4/1/2019.
F8 Option became exercisable in four equal annual installments, commencing 4/1/2020.
F9 The number of shares subject to the option were calculated using a 30-day average price.
F10 Option became exercisable in four equal annual installments, commencing 4/1/2021.
F11 Option becomes exercisable in four equal annual installments, commencing 4/1/2022.